Trial intelligence / Profile preview

Amlodipine crossover trial for cardiac iron in adult beta-thalassemia

IRCT20090613002027N15Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of amlodipine in beta thalassemia (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Cardiac MRI T2. Started Jan 2019; status: completed.

02

Drugs

amlodipine
03

Conditions

beta thalassemia

Beyond the preview

Go deeper on IRCT20090613002027N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20090613002027N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call